Stay updated on Pemigatinib Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed, indicating a minor navigational cleanup.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional cancer-related resources and medications, while removing some previous resources and location details.SummaryDifference5%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.2%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated to include detailed information about a clinical trial for pemigatinib, including study design, eligibility criteria, and treatment details. Additionally, it emphasizes that the U.S. government does not review or approve the safety and science of all studies listed on the site.SummaryDifference100%
Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.